Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03213574

Impact of GDT in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients

Impact of Goal Directed Fluid Therapy in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Loma Linda University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Robot assisted urological procedures are often long surgical cases that can potentially result in complicated postoperative hospital course. The amount of intravenous (IV) fluids administered to patients during these operations fluctuates based on the length of the case, surgical blood loss, hemodynamic monitors, and the discretion of the anesthesiologist. The goal of intraoperative fluid therapy is to maintain optimal tissue perfusion without causing fluid overload. We plan to use a goal directed fluid therapy protocol to optimize fluid status and analyze post-operative outcomes.

Conditions

Interventions

TypeNameDescription
OTHERControl GroupIntraoperative fluids will be administer per the discretion of anesthesia provider and not per SVV data or study protocol.
OTHERTreatment GroupFloTrac arterial line data will be used to administer fluid bolus, based on study algorithm.

Timeline

Start date
2017-12-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2017-07-11
Last updated
2018-04-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03213574. Inclusion in this directory is not an endorsement.